• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    8.49 Up 0.85(11.13%) Mar 4, 4:00PM EST
    |After Hours : 8.59 Up 0.10 (1.18%) Mar 4, 7:58PM EST
    Add to Portfolio
    Prev Close:7.64
    Open:8.00
    Bid:8.53 x 1900
    Ask:8.61 x 100
    1y Target Est:12.57
    Beta:2.68
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:7.75 - 9.02
    52wk Range:3.11 - 9.37
    Volume:40,680,408
    Avg Vol (3m):4,472,570
    Market Cap:1.05B
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 11.13%1.05B
    ABTDown 0.17%70.94B
    GSKUp 0.23%115.03B
    RHHBYDown 0.91%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.62
    Quarterly EPS Est (Mar-15) :-0.15
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.62

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback